Previous 10 | Next 10 |
Shares of Amphastar Pharmaceuticals (NASDAQ: AMPH) were up more than 15% early Wednesday afternoon, a day after the company reported fourth-quarter and annual earnings. The specialty pharmaceutical company focuses on innovative drug delivery systems for therapies, including injectable...
Gainers: Reata Pharmaceuticals ( RETA ) +176% . OncoSec Medical ( ONCS ) +118% . Sarepta Therapeutics ( SRPT ) +24% . PetIQ ( PETQ ) +17% . Amphastar Pharmaceuticals ( AMPH ) +15% . Losers: Novavax ( NVAX ) -24% . ...
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2022 Earnings Conference Call February 28, 2023 05:00 PM ET Company Participants Bill Peters - Chief Financial Officer, Treasurer, Executive Vice President of Finance, and President of IMS Ltd., and Director Dan Dischner - VP of Hu...
Amphastar Pharmaceuticals press release ( NASDAQ: AMPH ): Q4 Non-GAAP EPS of $0.73 beats by $0.33 . Revenue of $135M (+11.7% Y/Y) beats by $8.26M . Full-Year Highlights Net revenues of $499.0 million for the fiscal year GAAP net income of $91.4 millio...
Reports Net Revenues of $135.0 Million for the Three Months Ended December 31, 2022 RANCHO CUCAMONGA, CA / ACCESSWIRE / February 28, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months and full-year ended December 31...
RANCHO CUCAMONGA, CA / ACCESSWIRE / February 22, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2022 ended December 31, 2022, after the market closes on Tuesday, February 28, 2023, and will hold a conference call to ...
Summary Amphastar stock has generated high rates of post-tax earnings growth with small increments of additional capital investment since FY20. The incremental returns on capital are above historical returns on capital, illustrating the profitability of recent product launches over the ...
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 22, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, Sr. Vice President Regulatory Affairs and Clinical Operations, will participate in an Analyst-Moderated fireside chat at the Piper Sandl...
Summary Quarter-over-Quarter growth in revenue has persisted due to the consistent launch of new product pipelines. The overall financial position is substantially strong, which offers significant flexibility for the company. In my view, there is a significant growth opportuni...
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 10, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Jacob Liawatidewi, Executive V.P. of Corporate Administration Center, will participate in an Analyst-Moderated fireside chat at the 2022 Jefferies L...
News, Short Squeeze, Breakout and More Instantly...
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Complete Solaria Inc Com (CSLR) rose 58.5% to $1.775 on volume of 71,457,263 shares Senti Biosciences Inc. (SNTI) rose 55.1% to $0.428 on volume of 64,207,396 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 13.3% to $0.1711 on vo...
2024-06-19 18:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...